Skip to main content

Table 4 Multivariate Survival Analysis According To Clinical and Laboratory Parameters.

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Variable Hazard Ratio IC 95% Hazard ratio P
Liver Disease (yes vs no) 1.68 1.025–2.75 0.04
LDH (high vs normal) 1.89 1.17–3.06 0.009
Fibrinogen (high vs normal) 1.99 1.24–3.19 0.004
  1. Evaluated 129 pts (parameters considered: PS, liver disease, lymphocytes, LDH, ESR, PCR, Fibrinogen and WBC)